Vol 39, Issue 1

Only 13% to 50% of AN patients are considered recovered 1 to 2 years posttreatment, and 20% to 30% go on to develop a chronic and unremitting course of AN. How can we improve these outcomes?

OCD is highly comorbid and warrants consideration in difficult to treat cases. Learn more here.

Put treatment resistance in perspective with Sheldon H. Preskorn, MD.

Have you had difficulty with differential diagnosis when patients have manic symptoms and psychosis? One doctor discusses the related DSM-5 criteria changes and some of their implications for psychopharmacology.

Cryptocurrency can be complicated, but with these 5 tips, you can plan your best investment moves.

Wouter Kusters, PhD, uses his experiences with psychosis to better inform his philosophy. What can we learn from him?

"...barriers that create space for healing placed close enough to hear everyone’s cries of longing and love..."

Expect the unexpected: how doorknob moments provide valuable new material to help you move treatment forward.

What treatments were recently approved by the US Food and Drug Administration for pediatric patients with ADHD?

An estimated 7.7 million children have at least 1 mental health disorder. How can chatbots help?

Delirium: an underrecognized, underdiagnosed medical condition.

In this CME article, learn more about the controversies surrounding Lyme disease diagnosis and treatment, and common neuropsychiatric presentations of and treatment options.

The glass is half full: reflections on where we are and hope for where we are heading in psychiatry.

Paying tribute to a man who believed in family and health care equity.

How can we better define, clarify, and expand the Goldwater Rule for ethical and effective use in today's society?

Here's why we need more effective training, practice, and advocacy regarding the social determinants of mental health.